Reported 11 months ago
ABC-KY, a listed stock in Taiwan, experienced a remarkable surge of 60.38% last week, leading the market with five consecutive days of limit-up trading, fueled by the resurgence of COVID-19 pandemic. The company's respiratory panel kit has gained FDA approval and can detect 20 viruses and bacteria, making it a hot commodity in the epidemic prevention sector. With the anticipated peak of a new wave of COVID-19 cases and the approaching flu season, the demand for infectious disease testing is expected to drive ABC-KY's performance growth in the second half of the year, attracting significant attention from investors.
Source: YAHOO